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Integrated Model for Remodeling Processes in AF
Evidence for calcium overload





New experimental model for AF
Calcium Homeostasis
Studies showed that AF has the tendency to become more persistent over time. A
large percentage of patients with paroxysmal AF will develop persistent AF.1 Also,
pharmacological and electrical cardioversion and maintenance of sinus rhythm thereafter
become more difficult the longer the arrhythmia exists.2 Therefore it is important to study
the underlying mechanisms which play a role in the vulnerability to AF.
Experimental studies showed that electrical and contractile remodeling occur early
after the onset of AF (Figure 1A).3-5 Both remodeling processes were attenuated by blocking
of the L-type Ca2+ channel indicating that changes in the calcium homeostasis triggered by
tachycardia induced intracellular calcium overload, play a pivotal role in the induction of
atrial electrical remodeling and contractile dysfunction.
We first investigated the AF induced contractile dysfunction by studying the molecular
remodeling of proteins which influence calcium homeostasis (Chapter 2 and 3). The main
finding was reductions in mRNA and protein expression of the L-type calcium channel
and sarcoplasmatic reticulum Ca2+ ATPase (SR Ca2+ ATPase), predominantly in patients
with persistent AF. Also, an increased reduction in mRNA expression was found the longer
the duration of persistent AF existed. Patients with >6 months AF revealed reductions in
mRNA of L-type Ca2+ channel, in contrast to patients with <6 months duration of AF, in
whom no changes in mRNA expression were seen (Figure 1B and 2). This finding indicates
that changes in mRNA expression are the consequence rather than the cause of AF. The
results described in chapter 2 and 3 were confirmed by other studies which also showed
that the L-type Ca2+ channel6 and  SR Ca2+ ATPase6,7 were both reduced in AF. Unfortunately,
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in one study no time dependent changes in mRNA expression could be investigated since
the duration of AF was not known.7 Both studies were limited by differences between AF
and controls with respect to the underlying heart disease, which could have influenced
mRNA expression. Another limitation was that in both studies only mRNA expression of
L-type Ca2+ channel and SR Ca2+ ATPase was measured and no protein levels, which are
anticipated to represent the amount of functional proteins more adequately.
Taken together these studies indicate that changes in gene expression of proteins
influencing the calcium homeostasis occur in persistent AF. These changes probably are a
contributory factor for the atrial contractile dysfunction in AF.
Figure 1A.
Overview AF induced adaptations in experimental studies
Figure 1B.
Overview AF induced adaptations in human AF
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Ion-channel remodeling related to atrial refractory periods
It is well known that an abrupt increase in heart frequency, like in AF, causes an
immediate (within one action potential) and then a gradual (reaching steady state over
several minutes) decrease in action potential duration (APD).8 These alterations in APD
reduce atrial effective refractory period (AERP) and shorten the wavelength for reentry,
which will facilitate the occurrence and maintenance of reentrant arrhythmias like AF.
The rapid nature of these changes suggests that the short-term APD adaptation to rate is
due to functional changes in ion channels. With longer periods of sustained atrial
tachycardia, changes develop over the course of hours to days.4,9,10 The latter alterations
appear to concern mainly ion channel density and are due to modified gene expression
(Figure 1A,B).11,12 Most studies in changes of ion-channel protein expression have been
performed in animal experimental settings and gradually, studies have revealed that the
rapid shortening of the AERP in animal experimental AF mainly involves functional changes
in the L-type Ca2+ channel.11,12 In human AF the relationship between changes in AERP
and ion channel gene expression has not been investigated previously. We studied the
regulation of L-type Ca2+ channel and  K+ channels and their relation to AERP in patients
with persistent and paroxysmal AF (Chapter 5). We demonstrated a positive correlation
between the ion-channel protein expression of L-type Ca2+ channel, Kv4.3, Kv1.5, HERG,
minK and Kir3.1 and the AERP but also with the rate adaptation to AERP in patients with
persistent and paroxysmal AF. Low ion-channel protein levels were associated with short
AERP and poor rate adaptation. This indicates that electrical remodeling is paralleled by
general ion-channel protein reductions as part of the adaptation mechanisms during AF.
Since reduced ion-channel protein expression occurred due to AF we called this
phenomenon ion-channel remodeling. The ion-channel protein remodeling could play an
important role in the susceptibility to AF after restoration of sinus rhythm. Since shortening
of AERP can be explained by decrease in L-type Ca2+ channel and increase in K+ channel
gene expression or activity, the reductions in L-type Ca2+ channel could represent an
explanation for the electrophysiological changes during AF.
As noted the shortening in AERP can also be explained by an increase in K+ channel
activity and expression, we investigated the contribution of potassium channels in
paroxysmal and persistent AF (Chapter 4 and 5). Reductions in mRNA and protein levels
were found for several K+ channels in patients with persistent AF. In patients with
paroxysmal AF these reductions were observed predominantly at the protein level and not
at the mRNA level, suggesting the activation of a proteolytic system. The reductions in
mRNA and protein amount of K+ channels do not explain the shortening of AERP, however





 in isolated human atrial cells of patients with persistent AF due to
different underlying heart diseases.14 The apparent inconsistency between protein levels
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and current density can only be explained by assuming a change in single channel properties
in patients with persistent AF, such as an increase of mean open-time and increase in
channel conductance or a change in voltage dependency.
Unfortunately in human studies it is difficult to make a time course for remodeling
processes, but experimental data can elucidate the ion-channel remodeling in more detail.
Human and  experimental studies showed that brief periods of experimental AF (<1 h)
abbreviate AERP and favor AF induction via functional changes, including Ca2+ overload
induced L-type Ca2+ current (I
CaL
) inactivation, that cause APD shortening (Figure 1A,B).15,16
With longer periods of  sustained atrial tachycardia adaptations appear to involve alterations
mainly in ion channel density that are due to modified gene expression (Figure 1A,B and
2).11,12 An examination of ionic current changes in atrial myocytes from dogs subjected to
rapid atrial pacing for 7 and 42 days 11,12 indicated that high rate stimulation of atrial
myocytes does not change a variety of currents, including inward and delayed rectifier K+
currents, T-type Ca2+ current and Ca2+ dependent Cl- current. Currents that show important
alterations were the transient outward K+ current (I
To
) and L-type Ca2+ current (I
CaL
), both
of which are reduced by about 70% after 6 weeks of rapid atrial pacing due to reductions




, like voltage, time and frequency
Figure 2. Overview L-type calcium channel alterations
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dependence are unchanged. This observation suggests that the changes observed are due
to a reduction in the number of functional channels in the membrane rather than to a





 on the action potential showed that reductions in I
CaL
 are likely to
play the central role in the APD alterations caused by atrial tachycardia with the changes
in I
To
 being of much less importance,11 despite the quantitatively similar reduction.
 Thus, experimental and human AF studies reported important observations concerning
ion-channel remodeling. Although a difference in time course was found between human
and experimental AF. Changes in mRNA  expression were observed in animal experiments
around 1 week of AF, in human AF significant changes were observed only after > 6
months (Chapter 3) and >3 months6 (Figure 2), indicating that other factors play a role in
the adaptation mechanisms in human AF, for example preconditioning.
Furthermore in AF series of changes were found, involving rapid functional alterations
and slower changes in gene expression that cause APD reduction and reduced cellular
calcium loading. These changes can be considered to reduce I
CaL
 and thereby protect the
cell against potentially lethal Ca2+ overload resulting from an increase in rate of action
potential generation between resting sinus rhythm and AF. This protective effect occurs,
however, at the expense of electrophysiological changes that promote the maintenance of
AF.
Neurohumoral changes
The cardiac natriuretic peptide system and the endothelin system play an important
role in maintaining volume homeostasis especially in conditions that affect
hemodynamics.18,19 In Chapter 6 and 7 the local gene expression of these systems in atrial
tissue of patients with AF was studied. Persistent AF was associated with evident expression
of ANP and BNP mRNA and also endothelin-1 mRNA contents. The extent of these changes
was more pronounced in patients with concomitant valvular heart diseases, indicating that
these systems play a role in human AF and in particular in the presence of atrial pressure
or volume overload. Furthermore reductions were found in the protein expression of the
endothelin type A and B receptors during paroxysmal and persistent AF in contrast to
unchanged expression of mRNA amounts of these receptors suggesting post-transcriptional
regulation.
Post-transcriptional regulations
A remarkable finding during the study of mRNA and ion-channel protein remodeling
was a discrepancy between changes in mRNA and protein levels in patients with paroxysmal
AF (Chapter 4, 5 and 7). Whereas ion-channel protein levels of L-type Ca2+ channel, Kv1.5,
Kir3.1 and minK, but also ET-A were substantially decreased, the mRNA levels were
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essentially unaffected in paroxysmal AF. This discrepancy was also observed in other
studies20,21 and prompted us to explore the role of an adaptative mechanism of which the
influence in AF was unknown: the activation of a proteolytic system. Different proteolytic
pathways could be involved in AF. Since cytosolic calcium is increased during AF22,23,
proteolysis may be invoked by calcium dependent neutral proteases, calpain I and II.
Calpains are proteases which cleave mainly cytoskeletal and membrane-associated proteins
into ‘limited fragments’ without further degradation.24 In cardiac cells, calpains mediate
cell death in metabolically inhibited cultured rat cardiomyocytes and are involved in
troponin proteolysis and cross-linking following cardiac stunning and calcium overload.25-
27 In Chapter 8 an increased proteolytic activity in atrial tissue of patients with paroxysmal
and persistent lone AF was described. This increase was predominantly due to elevation
of calpain I activity and expression. Furthermore we observed that calpain I protein was
mainly localized at the nucleus and intercalated discs of atrial myocytes (Chapter 9). The
intensity of staining was low in sinus rhythm higher in paroxysmal AF and reached a
maximum in persistent AF. At the intercalated discs calpain can interact with Ca2+ and
thereby become an active proteinase and can degradate some important ion-channels like
the Na-channel28 and Kv1.519, but also several proteins directly involved in excitation-
contraction coupling.29 At the nucleus30 calpain can induce degenerative features leading
to apoptosis, which is observed in human AF (Figure 3).31
The role of calpain in cellular changes underlying the electrophysiological (Chapter
5), ion-channel (Chapter 5) and structural remodeling (Chapter 9) was examined. The
amount of structural and ultra-structural changes in the atrial tissue was examined by light









expression levels of ion-channel proteins, the degree of structural changes, measured AERP
and the rate adaptation coefficient of AERP. The results suggest that induction of calpain
activation represents a missing link between the calcium overload observed in AF22 and
remodeling of atrial myocytes during AF (Figure 3).
Integrated model for remodeling processes in AF
Evidence for AF induced Calcium overload
While studying the ion-channel gene expression adaptation mechanisms in human
AF, it became clear that the central feature in all these processes is calcium, in particular
calcium overload. Most investigations recognize the direct and indirect role of calcium
and our studies support the notion of calpain activation in AF. This notion is appealing
since it provides the molecular link between AF induced calcium overload and remodeling
processes, which was still not identified. Several lines of evidence for the crucial role of
AF induced calcium overload and subsequent calpain induction are reported below.
It has been proposed that atrial contractile dysfunction occurs after short-term and
chronic AF32-34 (Figure 1A,B). Contractile dysfunction after chronic AF is most likely
related to the cellular alterations in atrial myocytes35,36 reflected by structural alterations,
probably induced by proteolysis. The explanation for the atrial dysfunction after short-
term AF might be an increase in cytosolic Ca2+ due to the high rate of atrial activation. Fast
successive action potentials inhibit a proper sarcoplasmic reticulum Ca2+ re-uptake, resulting
in elevated cytosolic Ca2+, possibly impairing the excitation-contraction coupling and
contractile function.3,5,15,37,38 Ausma and coworkers showed that sarcolemma-bound Ca2+
and Ca2+ deposits in mitochondria increased markedly up to 2 weeks in experimental AF
and tends to regress towards normal levels at 4 and 8 weeks of AF (Figure 1A).22
Unfortunately, for Ca2+ localization they used antimonate based methods, which limit the
visualization of overall Ca2+ load at subcellular sites like the sarcoplasmic reticulum. Other
preliminary data showed that atrial tachycardia causes an immediate increase in cytoplasmic
Ca2+ concentration, which results in impaired Ca2+ release and cellular contractile
dysfunction after the cessation of tachycardia.23
Also other signaling pathway(s) by which AF leads to changes in atrial calcium
handling are involved. Recently completed experimental work suggests that T-type Ca2+
channels may mediate atrial tachycardia-induced electrical remodeling, because the T-
type Ca2+ channel blocker mibefradil limits both the ERP changes and AF promotion caused
by one week of rapid atrial pacing. Also in this case calcium overload would be prevented
by blocking a calcium channel.39
The similarity between the cellular ultrastructural changes caused by sustained AF
and those seen in hibernating myocardium40 have led to a suggestion that atrial ischemia
may play a role in triggering remodeling caused by AF. Whether ischemia occurs in AF is
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still debatable, but a reduced atrial blood flow in dogs with rapid pacing induced AF was
found and could result in atrial ischemia.41 A potential role for atrial ischemia is consistent
with the protective effect observed with blockade of the Na+/H+ exchanger in short term
tachycardia-induced atrial remodeling.42 In this model ischemia would give rise to a decrease
in intracellular pH, which leads to an exchange of intracellular hydrogen ions for
extracellular Na+ ions. Such an increase in intracellular Na+ results in a lower, or even
negative, equilibrium potential for the Na+/Ca2+ exchanger, thereby leading to a greater
magnitude of ‘reverse-mode’ functioning of the Na+/Ca2+ exchanger and therefore an influx
of Ca2+ ions.43 Alternatively, inhibition of the Na+/H+ exchanger may alter cellular ionic
homeostasis and combat calcium overload induced by ischemia.
In chapter 7 a mechanism that potentially modulates calcium overload in AF was
described. Studies on gene-expression of the endothelin system revealed that these systems
play a role in AF induced remodeling especially in patients with underlying valve disease.
We found that mRNA amounts of endothelin-1 are induced predominantly in persistent
AF with underlying valve disease. It is known that elevated endothelin-1 levels increase
intracellular calcium levels via the L-type Ca2+ channel44, indicating that calpain activation
also could play a role in AF with underlying valve disease, via different signal transduction
pathways. Moreover, increased amounts of BNP (Chapter 6) could be a compensatory
mechanism to reduce the intracellular calcium overload and thereby leading to relaxation
of the myocardial cell. BNP modulates cardiac calcium homeostasis via reduced intracellular
concentrations of cyclic adenosine monophosphate (cAMP), which inactivate the L-type
Ca2+ channel and activate the acetylcholine-dependent potassium channel leading to
repolarization of the action potential.18
Thus, several lines of evidence point to a central role of cellular calcium overload in
AF induced remodeling. Our work now reveals the potential role of calcium sensitive
processes that lead to changes in gene-expression and structural changes. Because elevated
levels of intracellular Ca2+ are known to activate proteolysis, this could result in increased
breakdown of myofilaments27,45 and ion-channel proteins (Chapter 9). In turn this could be
responsible for decreased contractility as well as for the vulnerability to AF.
Time course structural remodeling
In addition to electrophysiological, functional ion-current and ion-channel gene
expression changes, AF is associated with alterations in morphology. In Chapter 9 we
described an increase in degenerative contraction band necrosis observed in patients with
persistent and paroxysmal AF. Furthermore, we observed an increase in myocardial
hibernation (loss of sarcomeres and pale nuclei) only in patients with persistent AF, which
positively correlated with the duration of AF. This indicates that in human persistent AF
hibernation could be the specific structural change due to AF, in accordance with
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development of hibernation in the goat model for AF.40 We observed abundant degenerative
features in lone, paroxysmal AF. These could represent the prelude to the vulnerability to
AF by inducing dispersion of conduction (Figure 1B). Once persistent AF has been
developed, hibernation (which depends on prolonged periods of sustained AF) is more
abundant considered that cells liable to degeneration have now disappeared. These notions
are supported by the finding that in our patients with persistent AF, hibernation increased
with the duration of AF, while degeneration decreased. Possibly, hibernating myocardium
is protected against degeneration, as found after ischemic preconditioning.46 The reported
structural changes in human AF are in accordance with other studies. In humans structural
changes occur in atrial myocytes in patients with persistent AF.47 In patients with atrial
arrhythmias, myolysis and glycogen storage were only observed in a small number of
cells and that changes were frequently accompanied by lysosomal degeneration. In
experimental models these structural abnormalities appeared to be more pronounced when
the underlying pathology was aggravated by sustained AF.48,49 The occurrence of
degenerative myocardium could lead to increased dispersion of refractoriness and
conduction, which was found to enhance the inducibility and spontaneous occurrence of
idiopathic human AF.50 In addition to these defined changes in structural features, the
myocytes of AF patients displayed increased heterogeneity of cell size. Taken together,
the observed structural changes are indicative of a substantial deterioration of normal
tissue architecture, likely to promote AF through heterogeneity of atrial refractoriness50,51
and slowed atrial conduction.9,10,52 Since extreme physical stress, in combination with
sustained elevated cytosolic calcium levels, as in experimental AF22 often results in necrosis,
calpain could play an important role in this condition.53
In their model Ausma and coworkers noted mitochondrial enlargement, glycogen
accumulation, loss of sarcoplasmic reticulum and contractile elements in the atria of goats
subjected to chronic AF for upto 23 weeks.40 These changes resemble those observed in
the hibernating myocardium of the patients we investigated (Chapter 9). Recently the time
course of structural changes during AF in goats after 1-16 weeks of AF was studied.54
Here, the structural changes appeared to develop progressively, the earliest changes having
been noted after 1 week of AF and related to nuclear redistribution of heterochromatin
(Figure 1A). The nuclei showed a homogeneous distribution of chromatin, resembling
that found in embryonic/neonatal cardiomyocytes.40,55 After 4 weeks and at later times, AF
affected sarcomeres, glycogen, mitochondria and sarcoplasmatic reticulum simultaneously.
The loss of sarcoplasmatic reticulum and contractile proteins surely cause a decrease in
contractile force and hence atrial stunning54, which could be mediated by calpain.25,27
Since AF is promoted by slow conduction9,10,52,56 studies investigated the gap-junction
proteins, connexins, which play an important role in homogenous wavefront propagation
and conduction velocities in the heart.9,21,57,58 Gap-junctions are clusters of channels which
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span the closely apposed plasma membranes, forming cell-to-cell pathways. Connexins
are permeable to ions and small molecules up to 1 kDa in molecular mass, like second
messengers such as inositol triphosphate, cyclic AMP and calcium.
The initial data presented on changes in intercellular connexins were contradictory.
One study in the dog showed that AF increases connexin43 expression, the most abundant
connexin9 and another in the goat suggested that connexin43 is unaltered, but the distribution
of connexin40,  mainly present in atrium was altered.57  In a recent study the gap junctional
changes in relation to stabilization of AF were studied.21 In goats that were in sinus rhythm
the distribution of connexin40, a connexin that gives high conductance, was homogeneous.
After 2 weeks in AF, which was the time associated with markedly increased intracellular
Ca2+ deposition22 and just before AF became sustained, heterogeneity in the connexin40
distribution was observed. The connexin40 distribution pattern correlated with the
occurrence of structural changes (myolysis) in atrial myocytes .
The structural changes, myolysis and heterogeneity of connexin40 distribution,
possibly relate to calcium induced calpain activity and explain the slow recovery (weeks
to months) after cardioversion of AF in patients33,59, the contractile dysfunction5,34 and the
electrophysiological changes during AF.4
Electrophysiological properties
Over the past several years, AF-induced electrical remodeling and its underlying
mechanisms have been studied in substantial detail. In experimental studies part of the
underlying electrophysiological changes explaining the progressive nature of AF were
demonstrated.4,52 The increased tendency of the atria to fibrillate was paralleled by a
progressive shortening of the atrial effective refractory period (AERP) and loss of the
physiological rate adaptation of the refractory period which was termed atrial electrical
remodeling.4 The reduction in rate adaptation of the AERP is also observed in patients
with AF.60 All studies have shown that sustained atrial tachycardia decreases AERP and
changes occur over a period of days to weeks4,9,10,52, but AF can decrease AERP over a time
interval as short as several minutes (Figure 1A,B).15 Although the AERP reduction caused
by AF favors arrhythmia maintenance, it seems not be the only factor involved because
AF-induced AERP alterations become maximal well before AF-promoting effects
stabilize.4,10 One of the AF-promoting effects is tachycardia induced atrial conduction
slowing.9,10,52 It has a slower time course than AERP changes, probably due to delayed
onset of structural changes in the gap junctional remodeling21,57 and could account for at
least a part of the continued development of AF promotion after AERP changes have
stabilized. Whether gap junctional remodeling is caused by calpain induction is unknown,
but it is known that at least proteasome activity underlies a connexin43 degradation.61
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In addition to changes in the absolute value of AERP, atrial tachycardia alters the spatial
distribution of AERP. The spatial heterogeneity of AERP appears to be an important
determinant in the  maintainance ot AF50,51,62,63 and  there are indications that changed atrial
autonomic innervation, i.e. norephinephrine induced atrial sympathetic innervation, plays
an important role.64 Since norephinephrine causes elevation of the intracellular calcium
concentration in atrial myocytes, calpains might be activated and represent the causal link
to the maintenance of AF.
The combination of electrophysiological changes caused by sustained atrial tachycardia
i.e. reduced AERP, diminished or reversed adaptation to rate, slowed conduction and
increased spatial AERP heterogeneity, and the underlying structural changes caused by
calcium overload induced calpain ativity would be expected to promote AF maintenance
by enhancing the number of functional reentry circuits during AF.
Future perspectives
Pre-conditioning
The specific structural change induced by AF (Chapter 9) seemed to resemble chronic
hibernating myocardium.40 It is generally believed that by down-regulating their function,
cardiomyocytes adapt to a lowered oxygen availability and thereby restore the oxygen
supply/demand ratio. Part of the atrial cardiomyocytes acquired a dedifferentiated
phenotype, by re-expression of typical embryonic proteins. Furthermore, there is indirect
evidence that dedifferentiated,55 hibernating cardiomyocytes tolerate ischemia better than
non-dedifferentiated cardiomyocytes.65 It could be hypothesised that endogenous protective
mechanisms, such as an increased expression of certain heat shock proteins (stress induced
proteins which protects the cell against damage)66,  are up-regulated in AF induced
hibernating myocytes. Although direct evidence of such up-regulation is missing, it is
known that ischemic preconditioning induces the efficient translation of stress proteins.46
Several of these proteins are subsequently translocated to the nucleus, possibly to protect
against degradation of DNA that has become more susceptible to degradation due to a
transformation of the chromatin organisation into a nuclease-sensitive conformation (as is
the case in apoptosis).67,68 Heat shock proteins, such as Hsp70, Hsp27 and αB-crystallin
are known to protect against ischemic cardiac damage. Unlike ischemic preconditioning,
which also attenuates apoptotic cell death induced by ischemia/reperfusion in a pig model
of short-term hibernation69, mRNA expression of Hsp70 and several other apoptosis-
modulating proteins was not altered in the ventricle during coronary stenosis nor during
subsequent stunning.70 Still it could be worthwhile investigating the role of protective heat




Example of an agarose gel. Here the L-type calcium channel α1 subunit and the GAPDH are given. H9c2 cells
were stimulated 0, 12, 24 and 36 hours and 36 hours stimuation combined with 48 hours recovery. The amount
of L-type Ca2+ channel increased during the different stimulation protocols.





The chance of successful chemical cardioversion and/or prevention of AF is dependent
on the duration of AF. This clinically observed diminished efficacy of  cardioversion therapy
after long term AF cannot only by explained by the occurrrence of electrical remodeling.
The ion-channel protein remodeling and structural remodeling probably also affect the
electrophysiological function of the atrial myocardium.
In patients with persistent AF, there is a correlation between the duration of AF and
the time needed to recover atrial contractile function after cardioversion.33,71 The increase
in calpain activity which could lead to structural remodeling of the atrial myocytes might
give an explanation for the delay in recovery of contractile function in the atria after
conversion to sinus rhythm as seen in patients with persistent AF. Interference with the
calpain pathway by pharmacological intervention might represent an important new
therapeutic strategy to decrease protein degradation and thereby reduce the vulnerability
to AF. Calpain inhibitors as therapeutic agents are already used in nerve and muscle
degeneration72, but their potential benefit in heart diseases is not studied yet. After restoration
of normal sinus rhythm it may take the cardiomyocytes a certain period to rebuild a normal
amount of sarcomeres, if that is still possible at all.73 Data describing the recovery of ion-
channel protein expression are lacking, but a few reports describe, in contrast to the structural
remodeling, reversal of electrical remodeling in human AF after cardioversion.74,75 Since
AF induces remodeling in the atria it is essential to restore sinus rhythm as soon as possible,
thereby preventing the continuation of the atrial structural, ion-channel protein and electrical
remodeling.
Furthermore, differences in adaptation mechanisms which were found between patients
with lone AF and AF with underlying heart disease suggest the need for different
pharmacological treatment. For example, patients with elevated levels of endothelin could
be treated with an endothelin receptor antagonist, which has been shown to normalize
alterations in expression of various cardiac genes (like normalization of ryanodine receptor,
sarcoplasmic reticulum Ca2+ ATPase, angiotensin-converting enzyme, angiotensin II type




Calpain activation measurement in H9c2 cells.
The cells were stimulated 0, 20 and 30 hours.
An increase in calpain activity was found in
stimulated cells and inhibited by calpain I
inhibitor by 65%.hours of electrical stimulation0 5 10 15 20 25 30































New Experimental model for AF
To mimic human AF experimental models were developed. AF is studied in more
detail in different animal models. The dog10,38,52,77 and goat models4 for AF are well studied
and characterized. For studying molecular and cellular mechanisms the animal models
have disadvantages. First, in the animal a lot of (unknown) parameters can interfere with
the results. Second, animal models take time and are expensive and the third important
disadvantage is for the animal itself. These are reasons to think of a different experimental
model for AF, especially for studying the fundamental calcium sensitive pathways. A pos-
sible new model could be the electrical stimulation of myocardium cells. Pilot experi-
ments have been done for H9c2 cells, which are rat myoblast cells and are able to differen-
tiate into myotubes. H9c2 cells appear to be unique in that they express the cardiac isoforms
of the L-type Ca2+ channel alpha 1-subunit mRNA (data not shown). Another good candi-
date cell line is the immortalised HL-1 cells. These are contracting mouse atrial cells and
when electrically stimulated could mimic human AF.
For the electrical stimulation experiment a special culture flask was developed by
Popta and Henning. Pilot experiments were done to investigate changes in L-type Ca2+
channel mRNA expression and for measuring the calpain activation during electrical stimu-
lation in H9c2 myotubes. Therefore, the cells were stimulated for 12, 24 and 36 hours
followed by three days recovery (0.5 Hz, 25V). Figure 4 shows that in stimulated H9c2
cells the mRNA expression of the L-type Ca2+ a1 subunit was increased compared to
unstimulated H9c2 cells. Thus the H9c2 cell line may prove to be useful when studying
the regulation of subtype-specific Ca2+ channel gene expression. The second set of experi-
ments were done to measure the calpain activity with a calpain specific fluorogenic sub-
strate. The calpain activity increased significantly after 20 and 30 hours of stimulation
(Figure 5). This activity could be reduced by 65% by a specific inhibitor of calpain I.
These two sets of pilot experiments reveal that these cell models could represent excellent
models for studying the signaling pathways activated by electrical stimulation and the
tential benefits of pharmacological intervention in AF.
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In  conclusion, the combination of electrophysiological, ion-channel protein and struc-
tural remodeling caused by sustained AF would be expected to promote AF maintenance
by increasing the calcium overload induced calpain activity leading to induction of the
number of functional reentry circuits during AF. New cell models could be benificial for
studying the signaling pathways activated by electrical stimulation and pharmacological
intervention in AF.
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